In our experiment, we determined the activity of antioxidases and the content of lipid peroxides, and the findings showed that FSGLR (S7) and GIEWA (S10) could dose-dependently reduce the ROS level (Figure 6), significantly increase the activity of SOD, GSH-PX, and CAT, and reduce the MDA content (Figure 7) in the OA-induced NAFLD cell model. Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.